2 domains / 4 areas / 4 specializations
Psychedelic Alpha
Data updated
Psychedelic Alpha (Pα) is an independent, data-driven psychedelic media, research and advisory platform, founded in 2020 by Josh Hardman and based in London. It publishes the widely read weekly Psychedelic Bulletin newsletter alongside closely followed trackers of psychedelic drug development and of psychedelic law and policy, and provides advisory and consultancy services to investors, philanthropists, government agencies, startups and established firms. It is known for cutting through hype to surface what matters in the development, regulation and commercialisation of psychedelic medicines.
Consultancy & Advisory Snapshot
Commercial Strategy ConsultingGeography
Global
Coverage
Global
Psychedelic Focus
Explicit Psychedelic Focus
Engagement
Active
Pipeline Stage Coverage
Client Types
Consultancy Notes
Independent data-driven news and intelligence platform founded in 2020 by Josh Hardman, registered as Psy Alpha Ltd in England and Wales, covering psychedelic drug development, regulation and commercialisation. Alongside its bulletins, drug development tracker and legalisation tracker, it runs a selective advisory practice serving investors, philanthropists, government agencies, startups and large firms. Engagements range from one-off research calls and strategy sessions to retainer-based advisory and corporate briefings.
Media & Communication Snapshot
Psychedelic News & AnalysisCadence
Weekly
Access
Freemium
Psychedelic Focus
Explicit Psychedelic Focus
Verification
Verified
Audience
Coverage Focus
Media Notes
Psychedelic Alpha is an independent, data-driven news and intelligence platform covering psychedelic drug development, regulation, commercialisation and policy reform. It maintains widely cited resources including a drug development pipeline tracker, a legalisation and decriminalisation policy map and a sector job board. A free tier offers weekly news roundups, while the paid Pa+ subscription adds bulletins, interviews and deep-dive analysis.
Source Evidence
Quick Facts
- Type
- Other
- HQ
- United Kingdom
- Website
- Visit